Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Free Cash Flow | -$32.10M | -$59.50M | -$60.40M | -$199.30M | -$122.60M |
| -Change in Other Current Liabilities | $1.80M | -$1.30M | $1.20M | $1.20M | -$500,000.00 |
| -Change in Other Current Assets | -$4.30M | $7.50M | $2.80M | -$8.20M | -$3.90M |
| -Change in Inventory | -$50.40M | -$14.10M | $85.50M | -$94.90M | -$10.00M |
| -Change in Receivables | $4.80M | $62.30M | -$81.10M | $3.30M | $27.10M |
| Change in Working Capital | -$1.40M | $9.80M | $79.40M | -$73.70M | -$32.40M |
| Other Non-Cash Items | $5.20M | $4.00M | -$195.00M | $7.40M | $1.00M |
| Deferred Tax | $29.00M | $6.40M | $63.50M | $19.00M | $1.10M |
| Depreciation & Depletion & Amortization | $71.50M | $72.60M | $78.70M | $76.90M | $75.20M |
| Gain/Loss from Continuing Operations | -$141.00M | -$22.90M | -$54.60M | -$22.40M | -$10.60M |
| Net Income from Continuing Operations | $104.00M | $24.80M | $201.40M | $32.20M | $23.80M |
| Net cash flow from continuing operations | $72.80M | $99.60M | $179.70M | $45.30M | $63.50M |
| Operating Cash Flow | $68.90M | $97.80M | $177.40M | $44.20M | $61.60M |
| Cash Flow from Discontinued Operating Activities | -$3.90M | -$1.80M | -$2.30M | -$1.10M | -$1.90M |
| Net cash flow from investing | -$111.60M | -$70.20M | $12.80M | -$156.30M | -$150.50M |
| -Change in Payables and Accrued Expense | $46.70M | -$44.60M | $71.00M | $24.90M | -$45.10M |
| Beginning Cash Balance | $252.60M | $323.60M | $238.70M | $315.30M | $235.10M |
| Net Change in Cash | $17.30M | -$71.00M | $84.90M | -$76.60M | $80.20M |
| Ending Cash Balance | $269.90M | $252.60M | $323.60M | $238.70M | $315.30M |
| Net Other Financing Charges | $0.00 | -$4.20M | -$3.60M | -$5.00M | -$3.80M |
| Cash Dividends Paid | -$25.70M | -$24.80M | -$24.10M | -$24.20M | -$25.80M |
| Net Common Stock Issuance | -$22.20M | -$7.40M | -$12.70M | -$20.10M | -$38.70M |
| Net Issuance Payments Of Debt | $107.90M | -$62.20M | -$64.90M | $84.80M | $237.40M |
| Net Cash Flow from Continuing Financing Activities | $60.00M | -$98.60M | -$105.30M | $35.50M | $169.10M |
| Financing Cash Flow | $60.00M | -$98.60M | -$105.30M | $35.50M | $169.10M |
| Net PPE Purchase and Sale | $33.90M | $87.10M | $260.70M | $82.50M | $33.70M |
| Capital Expenditure | -$101.00M | -$157.30M | -$237.80M | -$243.50M | -$184.20M |
| Net Cash Flow from Continuing Investing Activities | -$111.60M | -$70.20M | $12.80M | -$156.30M | -$150.50M |
| Net Business Purchase and Sale | – | – | $6.70M | $4.70M | – |
No comments yet — be the first to weigh in on TRN.